Agios Pharmaceuticals AGIO Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Agios Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agios Pharmaceuticals's preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agios Pharmaceuticals's preferred stock, par or stated value per share?
- Agios Pharmaceuticals (AGIO) reported preferred stock, par or stated value per share of $0 in Q1 2026.
- How has Agios Pharmaceuticals's preferred stock, par or stated value per share changed year-over-year?
- Agios Pharmaceuticals's preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Agios Pharmaceuticals's preferred stock, par or stated value per share?
- Over 5 years (2020 to 2025), Agios Pharmaceuticals's preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.